185 related articles for article (PubMed ID: 10841824)
1. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism.
Loo TW; Clarke DM
J Natl Cancer Inst; 2000 Jun; 92(11):898-902. PubMed ID: 10841824
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram metabolites permanently inactivate the human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Mol Pharm; 2004; 1(6):426-33. PubMed ID: 16028354
[TBL] [Abstract][Full Text] [Related]
3. Almost serendipity: alcoholism drug reverses drug resistance in vitro.
Vastag B
J Natl Cancer Inst; 2000 Jun; 92(11):864-5. PubMed ID: 10841816
[No Abstract] [Full Text] [Related]
4. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
Orlowski S; Mir LM; Belehradek J; Garrigos M
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080
[TBL] [Abstract][Full Text] [Related]
5. Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites.
Teng YN; Huang BH; Huang SY; Wu IT; Wu TS; Lee TE; Hung CC
Biomed Pharmacother; 2021 Dec; 144():112379. PubMed ID: 34794239
[TBL] [Abstract][Full Text] [Related]
6. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
7. The human multidrug resistance P-glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy.
Loo TW; Clarke DM
FASEB J; 1999 Oct; 13(13):1724-32. PubMed ID: 10506575
[TBL] [Abstract][Full Text] [Related]
8. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
[No Abstract] [Full Text] [Related]
9. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
Sauna ZE; Peng XH; Nandigama K; Tekle S; Ambudkar SV
Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
[TBL] [Abstract][Full Text] [Related]
10. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
11. Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil.
Loo TW; Clarke DM
J Biol Chem; 2001 May; 276(18):14972-9. PubMed ID: 11279063
[TBL] [Abstract][Full Text] [Related]
12. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities.
Loo TW; Clarke DM
J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane.
Loo TW; Clarke DM
J Biol Chem; 1999 Dec; 274(50):35388-92. PubMed ID: 10585407
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates.
Loo TW; Clarke DM
J Biol Chem; 1996 Nov; 271(44):27482-7. PubMed ID: 8910331
[TBL] [Abstract][Full Text] [Related]
15. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2003 Dec; 278(50):50136-41. PubMed ID: 14522974
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
17. Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity.
Loo TW; Clarke DM
J Biol Chem; 1995 Sep; 270(39):22957-61. PubMed ID: 7559432
[TBL] [Abstract][Full Text] [Related]
18. HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.
Hu Z; Zhou Z; Hu Y; Wu J; Li Y; Huang W
PLoS One; 2015; 10(2):e0116886. PubMed ID: 25689592
[TBL] [Abstract][Full Text] [Related]
19. Drug-stimulated ATPase activity of the human P-glycoprotein.
Scarborough GA
J Bioenerg Biomembr; 1995 Feb; 27(1):37-41. PubMed ID: 7629050
[TBL] [Abstract][Full Text] [Related]
20. Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells.
Sachs CW; Ballas LM; Mascarella SW; Safa AR; Lewin AH; Loomis C; Carroll FI; Bell RM; Fine RL
Biochem Pharmacol; 1996 Aug; 52(4):603-12. PubMed ID: 8759033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
